A growing list of scientific studies have now shown that immunity following natural infection provides durable protection often far better than immunity following Covid-19 vaccination. Several governments focus on mandated vaccination. However natural immunity and a strong immune system are what are really needed to build full protection and a healthier population.
In most Western countries, vulnerable people and high-risk groups have been vaccinated with one of the four “Emergency Use Authorization” (EUA) Covid-19 vaccines. Remarkably, in the countries with the highest vaccination coverage (Israel, Iceland and England), we observe high numbers of positive tests.
Positive tests are called infections or cases, even though that may or may not be true (e.g., a PCR test may not distinguish between an active infection or a previous infection).
Contrary to inflated expectations, it appears that people who have been doubly vaccinated can test positive, carry a high viral load, potentially transmit the virus, and end up in the hospital. The effectiveness of vaccinations seems to be declining or disappearing. A “one size fits all” approach may become a dead end if we continue to pursue this current one-sided strategy with focus on just one virus.
In England, various immunologists have spoken out about the danger of a weakened immune system within the entire population, which increases the risk of infections and chronic diseases. As a result of the lockdowns and measures such as keeping one and a half meters distance and wearing masks, the immune system in many people may have weakened compared to the days before the pandemic.
The innate immune system is the first and not specific defense mechanism. It stops potential disease-causing organisms. This system is formed by physical barriers, such as skin, saliva, and mucous membranes. Switching to the adaptive immune system happens when the pathogen is able to break through the first barrier. Cells from the innate immune system present the pieces of the pathogen or foreign substance to B Cells and T cells of the adaptive immune system.